Règlement grand-ducal du 27 février 2018 modifiant le règlement grand-ducal du 1er décembre 2011 déterminant les critères, les conditions et la procédure relative à la fixation des prix des médicaments à usage humain. | http://data.legilux.public.lu/eli/etat/leg/rgd/2018/02/27/a167/jo — Luxembourg law | Esheria

Règlement grand-ducal du 27 février 2018 modifiant le règlement grand-ducal du 1er décembre 2011 déterminant les critères, les conditions et la procédure relative à la fixation des prix des médicaments à usage humain.

This is the preamble to a Grand-Ducal regulation that amends the 1 December 2011 regulation on the criteria, conditions, and procedure for setting prices of human medicines.

AI-assisted research synopsis — verify against the official legal text below.

Jurisdiction
Luxembourg
Instrument
Regulation
Citation
http://data.legilux.public.lu/eli/etat/leg/rgd/2018/02/27/a167/jo
Status
In force
Version
Undated source snapshot
Language
fr
Updated
Official source
View official record ↗
hospital medicines hospital use medicine pricing medicines pharmacist pricing documentation public listing

Publicly available, excluded from search-engine indexing

This page remains available for direct access and API use, but this release emits noindex,follow for the following reason:

  • The record does not meet this release's canonical indexing criteria. (market-indexing-disabled)

Statute overview

About this statute

This is the preamble to a Grand-Ducal regulation that amends the 1 December 2011 regulation on the criteria, conditions, and procedure for setting prices of human medicines. This provision changes wording in another regulation, replacing “de l’officine” with “de la pharmacie” in article 3(2). This article changes the wording of Article 12(2) so that the medicine is described as reserved for hospital use. If a request concerns certain hospital-only medicines, the public price equals the ex-factory price, or for medicines also on special medical prescription, the pharmacist’s purchase price. If no approved pharmacist’s purchase price exists in the country of origin, the holder must calculate it using the official calculation rules there and attach those rules to the request. Certain hospital-only medicines are entered on the positive list automatically, without an application, by decision of the President of the National Health Fund.